Product Images Oxaliplatin

This text appears to be a data table showing DFS (Disease Free Survival) probability over time, hazard ratio, logrank test result, number of events, and number of patients at risk over several months. The Hazard Ratio with a 95% confidence interval is reported as 0.80 with a range of 0.68 to 0.93. The Stratified Logrank Test resulted in a p-value of 0.003. The number of events is provided for two different groups (A and B), along with the percentage. The number of patients at risk over time is also listed.*

This text describes a comparison study of median survival rates between two different treatment combinations for patients, namely Oxaliplatin Injection USP with 5-FULV with a median survival of 19.4 months and Oxaliplatin Injection USP with irinotecan with a median survival of 17.6 months. The study reports statistical significance with a p-value of less than 0.0001 and also mentions the use of the log-rank test for the comparison of the two treatment regimens over a period of 24 months.*

This text contains information about a sterile aqueous solution of Oxaliplatin, a medication used for intravenous use only. The solution is preservative-free and comes in a 10 mL single-dose vial. The package insert provides instructions for required dilution and cautions against mixing with sodium chloride-containing solutions. The National Drug Code (NDC) for this product is 60505-6287-2.*

This text provides information about a pharmaceutical product manufactured by QILU Pharmaceutical (Hainan) Co., Ltd. and distributed by Apotex Corp. It includes details such as the GTIN, Lot number, expiration date, manufacturing and distribution locations, dosage strength, instructions for use, and precautions. The text also specifies that the product is a sterile aqueous solution, preservative-free, to be used for intravenous purposes only, and should not be mixed with or added to sodium chloride-containing solutions.*

Not available*